Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective

BACKGROUND: The Grazax Asthma Prevention (GAP) trial has recently demonstrated significant reductions in the odds of asthma symptoms or medication use in patients treated with SQ(®) grass SLIT-tablet relative to placebo, both in combination with allergy and asthma pharmacotherapy. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelberg, Christian, Hamelmann, Eckard, Wahn, Ulrich, Domdey, Anne, Pollock, Richard F, Grand, Tobias S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842901/
https://www.ncbi.nlm.nih.gov/pubmed/31807037
http://dx.doi.org/10.2147/CEOR.S223383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842901/
https://www.ncbi.nlm.nih.gov/pubmed/31807037
http://dx.doi.org/10.2147/CEOR.S223383

Ejemplares similares